Rafa Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RAFA LABS LTD, and what generic and branded alternatives to RAFA LABS LTD drugs are available?
RAFA LABS LTD has two approved drugs.
Drugs and US Patents for Rafa Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rafa Labs Ltd | ATROPINE (AUTOINJECTOR) | atropine | SOLUTION;INTRAMUSCULAR | 212319-001 | Jul 9, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Rafa Labs Ltd | MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) | midazolam hydrochloride | SOLUTION;INTRAMUSCULAR | 216359-001 | Aug 8, 2022 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.